Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Highly diluted atropine collyrium for slowing myopia progression in children
2024-515888-54-00Phase 3Authorised
- Sponsor
- Fakultní nemocnice Brno
- Start
- Nov 2024
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of atropine in myopia (3 arms), sponsored by Fakultní nemocnice Brno. Planned start Nov 2024; status: authorised.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on 2024-515888-54-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515888-54-00.